by Spoke Blog Admin | Jun 25, 2026 | Clinical Trials, Crohns Disease, Ulcerative Colitis
Inflammatory Bowel Disease (IBD), which primarily includes Crohn’s disease and Ulcerative Colitis, affects millions of people worldwide and continues to pose significant challenges for both patients and healthcare providers. These chronic inflammatory conditions of...
by Spoke Blog Admin | Mar 20, 2026 | Clinical Trials, Crohns Disease, Ulcerative Colitis
Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, is a lifelong condition that can be unpredictable, frustrating, and, at times, difficult to manage. While many patients find relief through standard treatments, others continue to...
by Spoke Blog Admin | Feb 20, 2026 | Clinical Trials, Crohns Disease
Crohn’s disease is a chronic inflammatory condition of the digestive tract that affects millions of people worldwide. Its symptoms — abdominal pain, diarrhoea, fatigue, weight loss, and bowel damage — can be debilitating and unpredictable. Despite significant...
by Spoke Blog Admin | Jan 20, 2026 | Clinical Trials, Crohns Disease
A new year often brings renewed motivation — a desire to take control of health, establish better habits, and move forward with clarity. For individuals living with inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, this “fresh start”...
by Spoke Blog Admin | Dec 20, 2025 | Clinical Trials
A new year always brings new goals, new plans, and new opportunities. Many people step into January with resolutions to eat better, exercise more, reduce stress, or take better care of their bodies. But if you’re living with a chronic condition—or supporting someone...
by Spoke Blog Admin | Nov 20, 2025 | Clinical Trials, Crohns Disease
A Clinical Research Perspective on Staying Healthy, Comfortable, and Prepared This Holiday Season The festive season is a time for celebration, family reunions, and well-earned relaxation. For many, it also means long-distance travel, airport queues, road trips, late...
